| Overview and outcome of mucormycosis among children with cancer: report from the Children's Cancer Hospital Egypt Y Madney, R Khedr, N Ahmed, H El‐Mahallawy, A Youssef, H Taha, ... Mycoses 62 (11), 984-989, 2019 | 23 | 2019 |
| Clinical features and outcome of hepatosplenic fungal infections in children with haematological malignancies Y Madney, L Shalaby, M Elanany, N Adel, E Nasr, K Alsheshtawi, ... Mycoses 63 (1), 30-37, 2020 | 17 | 2020 |
| Carbapenem-Resistant Enterobacteriaceae (CRE) among Children with Cancer: Predictors of Mortality and Treatment Outcome Y Madney, S Aboubakr, R Khedr, H Hafez, N Ahmed, K Elsheshtawy, ... Antibiotics 12 (2), 405, 2023 | 11 | 2023 |
| “Mucormycosis” the Emerging Global Threat; Overview and Treatment Outcome Among Pediatric Cancer Patients in Egypt Y Madney, R Khedr, H Al-Mahellawy, N Adel, H Taha, I Zaki, A Youssef, ... Blood 130, 4830, 2017 | 7 | 2017 |
| Outcome and safety of colistin usage in pediatric cancer patients with carbapenem-resistant enterobacteriaceae bacteremia at children cancer hospital Egypt N Adel, R Khedr, M Elanany, HF Zaki, H Hafez, H El-Abhar Annals of African Medicine 22 (1), 82-87, 2023 | 2 | 2023 |
| Echinocandin-Resistant Candidemia, the Next Upcoming Threat in the Era of Echinocandin Prophylaxis Among Pediatric Hematological Malignancies in Limited Resources Countries Y Madney, R Khedr, H Hafiz, L Shalby, M Gaber, K ELsheshtawy, N Adel, ... Blood 144, 7770, 2024 | | 2024 |
| Evaluating Clinical Outcomes, Resource Use and Economic Impact of Pediatric Cancer Patients with Solid Tumors Receiving Amphotericin-B Empirical Therapy at Children's Cancer … Y Madany, R Soliman, S Ahmed, L Shalaby, N Adel, A Elzeiny, M Gaber, ... PEDIATRIC BLOOD & CANCER 66, S529-S529, 2019 | | 2019 |
| Breakthrough Candidemia in Pedeatric Leukemia Patients Under Antifungal Prophylaxis: Clinical, Microbiological Characteristics and Treatment Outcome Y Madney, H Hafiz, R Khedr, L Shalaby, M Gaber, N Adel, K ELsheshtawy, ... PEDIATRIC BLOOD & CANCER 65, S524-S525, 2018 | | 2018 |
| INCREASING INCIDENCE OF CARBAPENEM-RESISTANT GRAM NEGATIVE BACTEREMIA AMONG PEDIATRIC CANCER PATIENTS R Khedr, H Ahmed, L Shalaby, N Adel, O Hasanain, H Al-mahallawy PEDIATRIC BLOOD & CANCER 60, 238-238, 2013 | | 2013 |
| INCIDENCE AND CLINICAL IMPACT OF EXTENDED SPECTRUM beta-LACTAMASE (ESBL) PRODUCTION AND CEPHALOSPORINE RESISTANCE IN BLOODSTREAM INFECTIONS IN PEDIATRIC CANCER PATIENTS L Shalaby, A Elhaddad, H Ahdelrahman, M Zamzam, G Gheith, ... PEDIATRIC BLOOD & CANCER 55 (5), 954-954, 2010 | | 2010 |
| Building the First ELearning Paediatric Oncology Clinical Pharmacy Program for Developing Countries O Hassanain, N Adel, M Kamal, S Abouelnaga, AS AlFaar | | |
Hanafy HafezProfessor of Pediatric Oncology and BMT, National Cancer Institute , Cairo University在 cu.edu.eg 的电子邮件经过验证
